Susquehanna International Group’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-52,600
| Closed | -$117K | – | 13933 |
|
|
2022
Q3 | $117K | Buy |
52,600
+21,700
| +70% | +$52.4K | ﹤0.01% | 11550 |
|
|
2022
Q2 | $64K | Buy |
30,900
+800
| +3% | +$1.98K | ﹤0.01% | 11827 |
|
|
2022
Q1 | $87K | Buy |
30,100
+2,300
| +8% | +$7.38K | ﹤0.01% | 12005 |
|
|
2021
Q4 | $89K | Sell |
27,800
-73,000
| -72% | -$249K | ﹤0.01% | 12217 |
|
|
2021
Q3 | $357K | Buy |
100,800
+66,300
| +192% | +$221K | ﹤0.01% | 10203 |
|
|
2021
Q2 | $109K | Sell |
34,500
-119,400
| -78% | -$376K | ﹤0.01% | 12053 |
|
|
2021
Q1 | $529K | Buy |
153,900
+66,200
| +75% | +$206K | ﹤0.01% | 9342 |
|
|
2020
Q4 | $221K | Buy |
+87,700
| New | +$191K | ﹤0.01% | 9880 |
|
|
2020
Q3 | – | Sell |
-11,600
| Closed | -$26K | – | 11269 |
|
|
2020
Q2 | $26K | Buy |
+11,600
| New | +$29.8K | ﹤0.01% | 9890 |
|
|
2018
Q2 | – | Sell |
-14,200
| Closed | -$78K | – | 10575 |
|
|
2018
Q1 | $78K | Buy |
14,200
+100
| +0.7% | +$704 | ﹤0.01% | 8805 |
|
|
2017
Q4 | $115K | Sell |
14,100
-13,300
| -49% | -$127K | ﹤0.01% | 8631 |
|
|
2017
Q3 | $287K | Buy |
+27,400
| New | +$304K | ﹤0.01% | 7483 |
|
|
2016
Q1 | – | Sell |
-31,600
| Closed | -$142K | – | 9792 |
|
|
2015
Q4 | $142K | Sell |
31,600
-2,100
| -6% | -$8.87K | ﹤0.01% | 8688 |
|
|
2015
Q3 | $107K | Buy |
+33,700
| New | +$102K | ﹤0.01% | 9106 |
|
|
2014
Q3 | – | Sell |
-29,000
| Closed | -$152K | – | 10033 |
|
|
2014
Q2 | $152K | Sell |
29,000
-18,100
| -38% | -$78.3K | ﹤0.01% | 9239 |
|
|
2014
Q1 | $196K | Buy |
47,100
+13,600
| +41% | +$46.6K | ﹤0.01% | 8255 |
|
|
2013
Q4 | $98K | Buy |
33,500
+20,100
| +150% | +$49.9K | ﹤0.01% | 8646 |
|
|
2013
Q3 | $34K | Sell |
13,400
-4,600
| -26% | -$10.9K | ﹤0.01% | 8283 |
|
|
2013
Q2 | $37K | Buy |
+18,000
| New | +$39.7K | ﹤0.01% | 8029 |
|
Other funds holding ENZ
RC
XT
KCM
GSC
Susquehanna International Group's ENZ Position: Q2 2025 in Review
Susquehanna International Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 60,041 shares — an estimated $22.2K sold.
Susquehanna International Group first reported a position in ENZ in Q2 2013 and held it in 32 quarters. The position peaked at $734K in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.
- Susquehanna International Group reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
- Susquehanna International Group sold 60,041 Enzo Biochem, Inc. shares in Q2 2025, an estimated $22.2K.
- Susquehanna International Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 32 quarters.
- Susquehanna International Group's Enzo Biochem, Inc. position peaked at $734K in Q2 2017.
- 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.
Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.